HOME OUR STORY OUR BUSINESSES OUR INVESTMENTS OUR COMMITMENTS OUR NEWS CONTACT SEARCH OUR INVESTMENTS ADial Pharmaceuticals ADial Pharmaceuticals develops prescription medications for addictions and related disorders. About ADial Pharmaceuticals focuses on gene-specific medication to treat addiction and related disorders. The medications target multiple neurotransmitters and brain pathways, which can help change how substance abuse is treated. ADial’s two most advanced compounds specifically target alcohol abuse and dependence. History ADial Pharmaceuticals is a start-up, with headquarters in Charlottesville, Virginia, USA. Ownership Lindéngruppen’s stake in ADial Pharmaceuticals is approximately 10%. For more information please visit www.adialpharma.com PRINT SHARE ON FACEBOOK – TWITTER – E-MAIL LINDÉNGRUPPEN AB, BRUKSGÅRDEN, SE-263 83 HÖGANÄS, SWEDEN – +46 (0)42 33 85 00 – INFO@LINDENGRUPPEN.SE